Data and Temporal Risk Concerns of Semaglutide and NAION—Reply - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Reply: Data Interpretation and Temporal Risk of Semaglutide-Associated NAION

  • By

  • Kent R. Heberer

  • Adam P. Bress

  • Jennifer S. Lee

  • October 1, 2026

Share

Original Source(s)

Data and Temporal Risk Concerns of Semaglutide and NAION—Reply

  • by Kent R. Heberer, Adam P. Bress, Jennifer S. Lee

  • October 1, 2026

Related Content

Safety and Effects of Gildeuretinol Acetate on Retinal Atrophic Lesions in Stargardt Disease: The TEASE-1

Efficacy and safety of port delivery platform with ranibizumab (PDS) for diabetic macular oedema (Pagoda Randomised Clinical Trial)

Persistent foetal vasculature: Developmental mechanisms, contemporary management and evolving therapeutics